Mastering Lyophilization: Overcoming development and optimization challenges

About this whitepaper:

Lyophilization is a vital tool to maintain product quality, extend shelf life, and protect delicate compounds.

This whitepaper takes a deep dive into the process, challenges, and intricacies of lyophilization cycle development and optimization. From understanding the benefits of lyophilization to detailing the development and optimization processes, we’ll cover the basics of lyophilization cycle development. We’ll also tackle key questions like when to introduce an annealing phase, how to address cake quality concerns, and how scale-up will affect the cycle design. By the end, you’ll be equipped with insights that can aid in your own drug product development and lyophilization cycle optimization, ensuring higher quality products. 

Download whitepaper

Mastering Lyophilization

Comments

This field is for validation purposes and should be left unchanged.

Name(Required)

First name Last name

Email(Required)

Company(Required)

At Sharp, we always have exciting pharma topics that we’d like to share with you. We will only contact you about topics that we think might be of interest, based on the information you provide to us.

Yes, I’d like to receive email updates from Sharp based on my details [1]

[1] Sharp takes your privacy seriously and will only use your personal information to provide services that you have requested from us. We will not share your personal information with non-agent third parties. View our privacy policy here.

utm_source

utm_medium

utm_campaign

Post Title

Submit

About the author

Saran Malhi is an Associate Director of MSAT and Technology Transfer at Sharp Sterile Manufacturing, with more than 10 years of experience in pharmaceutical formulation development, sterile manufacturing, process scale-up, and technology transfer. He holds a PhD in Pharmaceutics (Drug Delivery) from the University of Manitoba, along with an MSc in Pharmaceutics and a Bachelor of Pharmacy degree.

Dr. Malhi has led numerous clinical-to-commercial technology transfers and focuses on applying science- and risk-based approaches to develop robust, scalable manufacturing processes for complex and high-value therapies. His areas of expertise include aseptic fill-finish, lyophilization development and commercial scale-up, process optimization, technology transfer, process validation, and continued process verification.

• LinkedIn